489
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Virulence and Resistance Determinants of Uropathogenic Escherichia coli Strains Isolated from Pregnant and Non-Pregnant Women from Two States in Mexico

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 295-310 | Published online: 30 Jan 2020

References

  • Dirección General de Epidemiología. Boletín Epidemiológico. Sistema Nacional De Vigilancia Epidemiológica. Vol. 34 México, D.F: Sistema Único de Información; 2017.
  • Hill JB, Sheffield JS, Mcintire DD. Acute pyelonephritis in pregnancy. Am Fam Physician. 2005;42(4):1069. doi:10.1097/01.AOG.0000149154.96285.a0
  • Andreu A, Cacho J, Coira A, Lepe JA. Diagnóstico microbiológico de las infecciones del tracto urinario. Enferm Infecc Microbiol Clin. 2011;29(1):52–57. doi:10.1016/j.eimc.2010.06.008
  • Gilbert NM, O’brien VP, Hultgren S, Macones G, Lewis WG, Lewis AL. Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action. Glob Adv Heal Med. 2013;2(5):59–69. doi:10.7453/gahmj.2013.061
  • Nielubowicz GR, Mobley HLT. Host–pathogen interactions in urinary tract infection. Nat Rev Urol. 2010;7(8):430–441. doi:10.1038/nrurol.2010.10120647992
  • Hannan TJ, Totsika M, Mansfield KJ, Moore KH, Mark A, Hultgren SJ. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic E. coli bladder infection. NIH Public Access. 2013;36(3):616–648. doi:10.1111/j.1574-6976.2012.00339.x.Host-Pathogen
  • Kerure RD. Prevalence of asymptomatic bacteriuria among pregnant women in a tertiary care hospital. J Clin Diagn Res. 2013;3(11):11–14.
  • Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015;13(5):269–284. doi:10.1038/nrmicro343225853778
  • Wiles TJ, Kulesus RR, Mulvey MA. Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol. 2008;85:11–19. doi:10.1016/j.yexmp.2008.03.00718482721
  • Sainz E, Rosario T, Reyes M, Vicente P, Patricia M, Eslava C. Resistencia a antimicrobianos de cepas de E. coli de diversos serotipos aisladas de pacientes de un Hospital Psiquiátrico. Rev Mex Ciencias Farm. 2008;39(4):18–25.
  • Millán Y, Hernández E, Millán B, Araque M. Distribución de grupos filogenéticos y factores de virulencia en cepas de Escherichia coli uropatógena productora de β-lactamasa CTX-M-15 aisladas de pacientes de la comunidad en Mérida, Venezuela. Rev Argent Microbiol. 2014;46(3):175–181. doi:10.1016/S0325-7541(14)70069-025444124
  • Miranda-Estrada LI, Ruíz-Rosas M, Molina-López J, Parra-Rojas I, González-Villalobos E, Castro-Alarcón N. Relación entre factores de virulencia, resistencia a antibióticos y los grupos filogenéticos de Escherichia coli uropatógena en dos localidades de México. Enferm Infecc Microbiol Clin. 2017;35(7):426–433. doi:10.1016/j.eimc.2016.02.02127048964
  • Hojati Z, Molaie R, Gholipour A. The FimH gene in uropathogenic Escherichia coli strains isolated from patient with urinary tract infection. Jundishapur J Microbiol. 2015;8(2). doi:10.5812/jjm.17520
  • Rahdar M, Rashki A, Miri HR, Ghalehnoo MR. Detection of pap, sfa, afa, foc, and fim adhesin-encoding operons in uropathogenic Escherichia coli isolates collected from patients with urinary tract infection. Jundishapur J Microbiol. 2015;8(8). doi:10.5812/jjm.22647
  • Safi M, Achour W, Baaboura R, El Fatmi R, Ben Othmen T, Ben Hassen A. Distribution of virulence associated traits among urine Escherichia coli isolates from patients in onco-hematology. J Infect Chemother. 2016;22(4):221–224. doi:10.1016/j.jiac.2015.12.01726829995
  • Munkhdelger Y, Gunregjav N, Dorjpurev A, Juniichiro N, Sarantuya J. Detection of virulence genes, phylogenetic group and antibiotic resistance of uropathogenic Escherichia coli in Mongolia. J Infect Dev Ctries. 2017;11(01):51. doi:10.3855/jidc.790328141590
  • Rahdar M, Rashki A, Miri HR, Rashki Ghalehnoo M. Detection of pap, sfa, afa, foc, and fim adhesin-encoding operons in uropathogenic Escherichia coli isolates collected from patients with urinary tract infection. Jundishapur J Microbiol. 2015;8(8). doi:10.5812/jjm.22647
  • Ali I, Rafaque Z, Ahmed S, Malik S, Dasti JI. Prevalence of multi-drug resistant uropathogenic Escherichia coli in Potohar region of Pakistan. Asian Pac J Trop Biomed. 2016;6(1):60–66. doi:10.1016/j.apjtb.2015.09.022
  • Bien J, Sokolova O, Bozko P. Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol. 2012. doi:10.1155/2012/681473
  • Figueroa-Damián R, Velásquez P, Carrera A, Hernández-Valencia M. Consenso para el tratamiento de infecciones urinarias en ginecología. Perinat Reprod Hum. 2008;22:22–39.
  • Estrada AA, Figueroa DR, Villagana ZR. Infección de vías urinarias en la mujer embarazada. Importancia del escrutinio de bacteriuria asintomática durante la gestación. Perinatol Reprod Humana. 2010;24(3):182–186.
  • Calderón-Jaimes E. Diagnóstico y tratamiento de las infecciones en vías urinarias: un enfoque multidisciplinario para casos no complicados. Bol Med Hosp Infant Mex. 2013;70(1):3–10.
  • Salud S. Guía de Práctica Clínica: prevención, Dianóstico y Tratamiento de La Infección Del Tracto Urinario Bajo, Durante El Embarazo, En El Primer Nivel de Atencion [Clinical Practice Guide: Prevention, Diagnosis and Treatment of Low Urinary Tract Infection, During Pregnancy, At the First Level of Care]. 2016 Available from: http://www.cenetec-difusion.com/CMGPC/IMSS-078-08/ER.pdf. Accessed 1231, 2019.
  • Vallano A, Arnau JM. Antimicrobianos y embarazo. Enferm Infecc Microbiol Clin. 2009;27(9):536–542. doi:10.1016/j.eimc.2009.09.00119850375
  • World Health Organization. Antibiotic resistance. Available from: http://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Accessed 1231, 2019 Published 2018.
  • Alqasim A, Abu Jaffal A, Alyousef AA. Prevalence of multidrug resistance and extended-spectrum β -lactamase carriage of clinical uropathogenic Escherichia coli isolates in Riyadh, Saudi Arabia. Int J Microbiol. 2018;2018:1–9. doi:10.1155/2018/3026851
  • Malekzadegan Y, Khashei R, Sedigh Ebrahim-Saraie H, Jahanabadi Z. Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients. BMC Infect Dis. 2018;18(1):1–9. doi:10.1186/s12879-018-3467-029291713
  • Bajpai T, Pandey M, Varma M, Bhatambare G. Prevalence of TEM, SHV, and CTX-M Beta-Lactamase genes in the urinary isolates of a tertiary care hospital. Avicenna J Med. 2017;7(1):12. doi:10.4103/2231-0770.19750828182026
  • Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–976. doi:10.1128/AAC.01009-0919995920
  • Bonomo RA. β-lactamases: A Focus on Current Challenges. Cold Spring Harb Perspect Med. 2017;7:a025239. doi:10.1101/cshperspect.a025239
  • Organizacion Mundial de la Salud. Guía sobre la reglamentación relativa al transporte de sustancias infecciosas 2013–2014: aplicable a partir de 1 de enero de 2013. Plant Dis. 2012;96. doi:10.1094/PDIS-11-11-0999-PDN
  • Ørskov F, Ørskov I. 2 Serotyping of Escherichia coli. Methods Microbiol. 1984;43–112. doi:10.1016/S0580-9517(08)70447-1
  • Sambrook J. Molecular Cloning a Laboratory Manual. Vol. 33 2012. doi:10.3724/SP.J.1141.2012.01075
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Fifth Informational Supplement; 2017.
  • Magiorakos A, Srinivasan A, Carey RB, et al. Bacteria: an international expert proposal for interim standard definitions for acquired resistance. Microbiology. 2011;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
  • Sabate M, Moreno E, Perez T, Andreu A, Prats G. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect. 2006;12(9):880–886. doi:10.1111/j.1469-0691.2006.01461.x16882293
  • Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5(1):58–65. doi:10.1111/1758-2229.1201923757131
  • Milagres AMF, Machuca A, Napoleão D. Detection of siderophore production from several fungi and bacteria by a modification of chrome azurol S (CAS) agar plate assay. J Microbiol Methods. 1999;37(1):1–6. doi:10.1016/S0167-7012(99)00028-710395458
  • Shin SH, Lim Y, Lee SE, Yang NW, Rhee JH. CAS agar diffusion assay for the measurement of siderophores in biological fluids. J Microbiol Methods. 2001;44(1):89–95. doi:10.1016/S0167-7012(00)00229-311166103
  • Pérez-Miranda S, Cabirol N, George-Téllez R, Zamudio-Rivera LS, Fernández FJ. O-CAS, a fast and universal method for siderophore detection. J Microbiol Methods. 2007;70(1):127–131. doi:10.1016/j.mimet.2007.03.02317507108
  • da Silva GJ, Mendonça N. Association between antimicrobial resistance and virulence in Escherichia coli. Virulence. 2012;3(1):18–28. doi:10.4161/viru.3.1.1838222286707
  • Brennan DE, Dowd C, O’Morain C, McNamara D, Smith SM. Can bacterial virulence factors predict antibiotic resistant Helicobacter pylori infection? World J Gastroenterol. 2018;24(9):971–981. doi:10.3748/wjg.v24.i9.97129531461
  • Ochoa SA, Cruz-Córdova A, Luna-Pineda VM, et al. Multidrug- and extensively drug-resistant uropathogenic Escherichia coli clinical strains: phylogenetic groups widely associated with integrons maintain high genetic diversity. Front Microbiol. 2016;7(DEC). doi:10.3389/fmicb.2016.02042
  • Abiodun AO, Olufunke OA, Dunah FC, Oladiran F. Phenotypic identification and phylogenetic characterization of uropathogenic escherichia coli in symptomatic pregnant women with urinary tract infections in South-Western Nigeria. Int J Biol. 2014;6(4). doi:10.5539/ijb.v6n4p145
  • Ramos NL, Sekikubo M, Dzung DTN, et al. Uropathogenic Escherichia coli isolates from pregnant women in different countries. J Clin Microbiol. 2012;50(11):3569–3574. doi:10.1128/JCM.01647-1222915606
  • Al-Mayahie SMG. Phenotypic and genotypic comparison of ESBL production by vaginal Escherichia coli isolates from pregnant and non-pregnant women. Ann Clin Microbiol Antimicrob. 2013;12:7. doi:10.1186/1476-0711-12-723617811
  • Rice LB. Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc. 2012;87(2):198–208. doi:10.1016/j.mayocp.2011.12.00322305032
  • Worthington RJ, Melander C. Overcoming resistance to β-lactam antibiotics. J Org Chem. 2013;78(9):4207–4213. doi:10.1021/jo400236f23530949
  • Eto DS, Jones TA, Sundsbak JL, Mulvey MA. Integrin-mediated host cell invasion by type 1–piliated uropathogenic Escherichia coli. PLoS Pathog. 2007;3(7):e100. doi:10.1371/journal.ppat.003010017630833
  • Martinez JJ, Hultgren SJ. Requirement of Rho-family GTPases in the invasion of type 1-piliated uropathogenic Escherichia coli. Cell Microbiol. 2002;4(1):19–28. doi:10.1046/j.1462-5822.2002.00166.x11856170
  • Guiton PS, Cusumano CK, Kline KA, et al. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice. Antimicrob Agents Chemother. 2012;56(9):4738–4745. doi:10.1128/AAC.00447-1222733070
  • Autún Rosado DP, Sanabria Padrón VH, Figueroa EHC, Rangel Villaseñor O, Hernández-Valencia M. Etiología y frecuencia de bacteriuria asintomática en mujeres embarazadas. Perinatol Reprod Hum. 2015;29(4):148–151. doi:10.1016/j.rprh.2016.02.001
  • Vallejos Medic C, López Villegas MDR, Enríquez Guerra MÁ, Ramírez Valverde B. Prevalencia de infecciones de vías urinarias en embarazadas atendidas en el Hospital Universitario de Puebla. Enfermedades Infec Microbiol. 2010;30(4):118–122.
  • Hantke K. Identification of an iron uptake system specific for coprogen and rhodotorulic acid in Escherichia coli K12. Mol Gen Genet. 1983;191:301–306. doi:10.1007/BF03348306353165
  • Garcia EC, Brumbaugh AR, Mobley HLT. Redundancy and specificity of escherichia coli iron acquisition systems during urinary tract infection. Payne SM, ed. Infect Immun. 2011;79(3):1225–1235. doi:10.1128/IAI.01222-1021220482
  • Herlax V, Maté S, Rimoldi O, Bakás L. Relevance of fatty acid covalently bound to escherichia coli α-hemolysin and membrane microdomains in the oligomerization process. J Biol Chem. 2009;284(37):25199–25210. doi:10.1074/jbc.M109.00936519596862
  • Bakás L, Maté S, Vazquez RHV. E. coli alpha-hemolysin and properties In: Ekinci D, editor. Biochemistry. Rijeka, Croacia: InTech; 2012:107–140.
  • Naderi G, Haghi F, Zeighami H, Hemati F, Masoumian N. Distribution of pathogenicity island (PAI) markers and phylogenetic groups in diarrheagenic and commensal Escherichia coli from young children. Gastroenterol Hepatol Bed Bench. 2016;9(4):316–324.27895858
  • Messerer M, Fischer W, Schubert S. Investigation of horizontal gene transfer of pathogenicity islands in Escherichia coli using next-generation sequencing. PLoS One. 2017;12(7):1–17. doi:10.1371/journal.pone.0179880
  • Navidinia M, Najar Peerayeh S, Fallah F, et al. Distribution of the pathogenicity islands markers (PAIs) in uropathogenic E.coli isolated from children in mofid children hospital. Arch Pediatr Infect Dis. 2013;1(2):75–79. doi:10.5812/pedinfect.9083
  • Samei A, Haghi F, Zeighami H. Distribution of pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Folia Microbiol (Praha). 2016;61(3):261–268. doi:10.1007/s12223-015-0433-826563230
  • Tangi SC, Tajbakhsh E, Soleimani NA, Shahraki MM. Prevalence of pathogenicity island markers genes in uropathogenic Escherichia coli isolated from patients with urinary tract infectious. Asian Pacific J Trop Dis. 2015;5(8):662–666. doi:10.1016/S2222-1808(15)60909-4
  • Bielaszewska M, Schiller R, Lammers L, et al. Heteropathogenic virulence and phylogeny reveal phased pathogenic metamorphosis in Escherichia coli O2: H6. EMBO Mol Med. 2014;6(3):347–357. doi:10.1002/emmm.20130313324413188
  • Poppe C, Martin L, Gyles C, et al. Acquisition and transfer of resistance to extended-spectrum cephalosporins by Salmonella Newport and E. coli in the intestinal tract of turkey poults. Guelph Food Saf Semin Ser Symp Guelph. 2004;71(3):1184–1192. doi:10.1128/AEM.71.3.1184
  • Pearce JL, Bettelheim KA, Luke RKJ, Goldwater PN. Serotypes of Escherichia coli in sudden infant death syndrome. J Appl Microbiol. 2010;108(2):731–735. doi:10.1111/j.1365-2672.2009.04473.x19674183
  • Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000;66(10):4555–4558. doi:10.1128/AEM.66.10.4555-4558.200011010916